Stifel Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,955
| Closed | -$118K | – | 3632 |
|
|
2025
Q2 | $118K | Sell |
12,955
-288
| -2% | -$2.12K | ﹤0.01% | 3347 |
|
|
2025
Q1 | $105K | Buy |
13,243
+435
| +3% | +$3.19K | ﹤0.01% | 3293 |
|
|
2024
Q4 | $69.6K | Buy |
12,808
+761
| +6% | +$4.65K | ﹤0.01% | 3292 |
|
|
2024
Q3 | $87K | Sell |
12,047
-3,402
| -22% | -$31.1K | ﹤0.01% | 3259 |
|
|
2024
Q2 | $168K | Buy |
15,449
+1,564
| +11% | +$20K | ﹤0.01% | 3141 |
|
|
2024
Q1 | $260K | Sell |
13,885
-84
| -0.6% | -$1.94K | ﹤0.01% | 2984 |
|
|
2023
Q4 | $303K | Sell |
13,969
-3,617
| -21% | -$71.7K | ﹤0.01% | 2840 |
|
|
2023
Q3 | $362K | Sell |
17,586
-20,967
| -54% | -$606K | ﹤0.01% | 2679 |
|
|
2023
Q2 | $1.81M | Sell |
38,553
-2,887
| -7% | -$144K | ﹤0.01% | 1693 |
|
|
2023
Q1 | $1.74M | Sell |
41,440
-6,330
| -13% | -$272K | ﹤0.01% | 1671 |
|
|
2022
Q4 | $1.82M | Sell |
47,770
-1,615
| -3% | -$61.7K | ﹤0.01% | 1585 |
|
|
2022
Q3 | $1.93M | Sell |
49,385
-5,633
| -10% | -$218K | ﹤0.01% | 1500 |
|
|
2022
Q2 | $1.78M | Sell |
55,018
-12,126
| -18% | -$406K | ﹤0.01% | 1571 |
|
|
2022
Q1 | $2.22M | Buy |
67,144
+21,702
| +48% | +$816K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $1.93M | Sell |
45,442
-10,476
| -19% | -$439K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $2.48M | Sell |
55,918
-268
| -0.5% | -$12.3K | ﹤0.01% | 1437 |
|
|
2021
Q2 | $3.19M | Buy |
56,186
+6,967
| +14% | +$492K | ﹤0.01% | 1279 |
|
|
2021
Q1 | $3.68M | Sell |
49,219
-19,402
| -28% | -$1.59M | 0.01% | 1133 |
|
|
2020
Q4 | $5.94M | Buy |
68,621
+9,033
| +15% | +$666K | 0.01% | 808 |
|
|
2020
Q3 | $3.64M | Buy |
59,588
+16,160
| +37% | +$819K | 0.01% | 916 |
|
|
2020
Q2 | $1.8M | Buy |
43,428
+19,576
| +82% | +$711K | ﹤0.01% | 1217 |
|
|
2020
Q1 | $688K | Sell |
23,852
-24,453
| -51% | -$1.42M | ﹤0.01% | 1659 |
|
|
2019
Q4 | $3.49M | Buy |
48,305
+35,210
| +269% | +$4.33M | 0.01% | 1027 |
|
|
2019
Q3 | $1.84M | Sell |
13,095
-6,165
| -32% | -$1.03M | ﹤0.01% | 1365 |
|
|
2019
Q2 | $3.51M | Sell |
19,260
-18
| -0.1% | -$3.07K | 0.01% | 1005 |
|
|
2019
Q1 | $3.04M | Buy |
19,278
+14,241
| +283% | +$2.06M | 0.01% | 1028 |
|
|
2018
Q4 | $485K | Sell |
5,037
-1,445
| -22% | -$165K | ﹤0.01% | 1952 |
|
|
2018
Q3 | $921K | Buy |
6,482
+349
| +6% | +$53.9K | ﹤0.01% | 1729 |
|
|
2018
Q2 | $962K | Buy |
+6,133
| New | +$963K | ﹤0.01% | 1641 |
|
|
2017
Q3 | – | Sell |
-4,998
| Closed | -$401K | – | 2636 |
|
|
2017
Q2 | $401K | Buy |
+4,998
| New | +$361K | ﹤0.01% | 1988 |
|
|
2015
Q2 | – | Sell |
-158,036
| Closed | -$7.94M | – | 2415 |
|
|
2015
Q1 | $7.94M | Buy |
158,036
+57,775
| +58% | +$2.48M | 0.04% | 470 |
|
|
2014
Q4 | $5.72M | Buy |
+100,261
| New | +$3.74M | 0.03% | 552 |
|
Other funds holding SAGE
IA
HNB
Stifel Financial's SAGE Position: Q3 2025 in Review
Stifel Financial sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 12,955 shares — an estimated $118K sold.
Stifel Financial first reported a position in SAGE in Q4 2014 and held it in 32 quarters. The position peaked at $7.94M in Q1 2015. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Stifel Financial reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Stifel Financial sold 12,955 Sage Therapeutics shares in Q3 2025, an estimated $118K.
- Stifel Financial first reported a position in Sage Therapeutics in Q4 2014 and held it in 32 quarters.
- Stifel Financial's Sage Therapeutics position peaked at $7.94M in Q1 2015.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Stifel Financial's 13F filing for Q3 2025, filed 12 Nov 2025.